Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BNR NYSE:ORI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNRBurning Rock Biotech$8.15+0.7%$8.56$2.18▼$11.12$87.65M0.9829,951 shs5,424 shsORIOld Republic International$41.03-4.1%$40.54$33.00▼$44.00$10.21B0.761.32 million shs1.03 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNRBurning Rock Biotech-4.71%-9.10%-7.12%+75.49%+179.93%ORIOld Republic International-1.70%-1.25%+7.24%+16.39%+19.04%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBNRBurning Rock Biotech$8.15+0.7%$8.56$2.18▼$11.12$87.65M0.9829,951 shs5,424 shsORIOld Republic International$41.03-4.1%$40.54$33.00▼$44.00$10.21B0.761.32 million shs1.03 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBNRBurning Rock Biotech-4.71%-9.10%-7.12%+75.49%+179.93%ORIOld Republic International-1.70%-1.25%+7.24%+16.39%+19.04%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBNRBurning Rock Biotech 1.00SellN/AN/AORIOld Republic International 3.67Strong Buy$47.0014.54% UpsideCurrent Analyst Ratings BreakdownLatest ORI, CRDA, 1COV, BNR, and JMAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025BNRBurning Rock BiotechWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025ORIOld Republic InternationalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (A-)10/6/2025ORIOld Republic InternationalPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$45.00 ➝ $47.009/27/2025BNRBurning Rock BiotechWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025ORIOld Republic InternationalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (A-)9/22/2025ORIOld Republic InternationalRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$43.00 ➝ $47.009/2/2025ORIOld Republic InternationalPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$41.00 ➝ $45.007/25/2025ORIOld Republic InternationalPiper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$42.00 ➝ $41.00(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBNRBurning Rock Biotech$536.30M0.16N/AN/A$7.39 per share1.10ORIOld Republic International$8.23B1.24$2.96 per share13.84$22.16 per share1.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBNRBurning Rock Biotech-$47.49M-$1.90N/A∞N/A-26.04%-23.61%-15.73%12/2/2025 (Estimated)ORIOld Republic International$852.80M$2.9214.0712.32N/A10.31%20.95%4.45%10/23/2025 (Estimated)Latest ORI, CRDA, 1COV, BNR, and JMAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/23/2025Q3 2025ORIOld Republic International$0.73N/AN/AN/A$2.28 billionN/A9/8/2025Q2 2025BNRBurning Rock BiotechN/A-$0.15N/A-$0.15N/A$20.74 million7/24/2025Q2 2025ORIOld Republic International$0.79$0.83+$0.04$0.81$2.18 billion$2.21 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBNRBurning Rock BiotechN/AN/AN/AN/AN/AORIOld Republic International$1.162.83%N/A39.73%45 YearsLatest ORI, CRDA, 1COV, BNR, and JMAT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/15/2025ORIOld Republic Internationalquarterly$0.292.87%9/5/20259/5/20259/15/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBNRBurning Rock BiotechN/A3.222.97ORIOld Republic International0.260.250.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBNRBurning Rock Biotech30.03%ORIOld Republic International70.92%Insider OwnershipCompanyInsider OwnershipBNRBurning Rock Biotech30.30%ORIOld Republic International1.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBNRBurning Rock Biotech1,39010.76 million7.50 millionNot OptionableORIOld Republic International9,400248.47 million245.74 millionOptionableORI, CRDA, 1COV, BNR, and JMAT HeadlinesRecent News About These CompaniesOld Republic International (ORI) to Release Earnings on ThursdayOctober 16 at 2:20 AM | marketbeat.comRitholtz Wealth Management Has $22.23 Million Stake in Old Republic International Corporation $ORIOctober 15 at 6:20 AM | marketbeat.comWhy Old Republic International (ORI) is a Great Dividend Stock Right NowOctober 14 at 12:47 PM | zacks.comKiker Wealth Management LLC Takes Position in Old Republic International Corporation $ORIOctober 14 at 6:57 AM | marketbeat.comCallan Family Office LLC Grows Stake in Old Republic International Corporation $ORIOctober 14 at 3:44 AM | marketbeat.comLeith Wheeler Investment Counsel Ltd. Sells 180,149 Shares of Old Republic International Corporation $ORIOctober 13 at 6:47 AM | marketbeat.comCyndeo Wealth Partners LLC Buys 10,568 Shares of Old Republic International Corporation $ORIOctober 11, 2025 | marketbeat.comWealthstar Advisors LLC Acquires 6,996 Shares of Old Republic International Corporation $ORIOctober 11, 2025 | marketbeat.comOld Republic International's (ORI) Buy (A-) Rating Reaffirmed at Weiss RatingsOctober 10, 2025 | marketbeat.comPiper Sandler Keeps Their Buy Rating on Old Republic International (ORI)October 9, 2025 | theglobeandmail.comOLD REPUBLIC INTERNATIONAL ANNOUNCES THIRD QUARTER 2025 EARNINGS CALLOctober 9, 2025 | prnewswire.comQRG Capital Management Inc. Has $934,000 Position in Old Republic International Corporation $ORIOctober 9, 2025 | marketbeat.com8,205 Shares in Old Republic International Corporation $ORI Acquired by 111 CapitalOctober 7, 2025 | marketbeat.comOld Republic International (NYSE:ORI) Hits New 52-Week High - Here's WhyOctober 6, 2025 | marketbeat.comORI Outperforms Industry, Hits 52-Week High: How to Play the StockOctober 6, 2025 | zacks.comDoes Old Republic's (ORI) New Environmental Subsidiary Signal a Shift in Specialty Insurance Strategy?October 6, 2025 | finance.yahoo.comWoodmont Investment Counsel LLC Buys 10,311 Shares of Old Republic International Corporation $ORIOctober 6, 2025 | marketbeat.comHennessy Advisors Inc. Invests $8.61 Million in Old Republic International Corporation $ORIOctober 4, 2025 | marketbeat.comLecap Asset Management Ltd. Decreases Stock Position in Old Republic International Corporation $ORIOctober 3, 2025 | marketbeat.comCHURCHILL MANAGEMENT Corp Sells 7,533 Shares of Old Republic International Corporation $ORIOctober 2, 2025 | marketbeat.comOld Republic launches specialty environmental insurerSeptember 30, 2025 | captiveinsurancetimes.comCNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAfter the Fed's Rate Cut, PNC Could See a Mortgage Refinance BoomBy Jordan Chussler | September 21, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 2025Which National Chains Do People Wish Were in Their State? [2025 Survey]By MarketBeat Staff | September 30, 2025General Mills Is a Generational Opportunity for Income InvestorsBy Thomas Hughes | September 18, 20253 Emerging Stocks You Haven't Heard Much From This CycleBy Gabriel Osorio-Mazilli | September 29, 2025ORI, CRDA, 1COV, BNR, and JMAT Company DescriptionsBurning Rock Biotech NASDAQ:BNR$8.14 +0.06 (+0.68%) As of 02:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.Old Republic International NYSE:ORI$41.03 -1.77 (-4.13%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Old Republic International Corporation, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. It operates through three segments: General Insurance, Title Insurance, and Republic Financial Indemnity Group Run-off Business. The General Insurance segment offers aviation, commercial auto, commercial multi-peril, commercial property, general liability, home and auto warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, directors and officers, and surety. This segment provides its insurance products to businesses, state and local government, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. The Republic Financial Indemnity Group Run-off Business segment offers private mortgage insurance coverage that protects mortgage lenders and investors from default related losses on residential mortgage loans made primarily to homebuyers. Old Republic International Corporation was founded in 1923 and is based in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Qualcomm: What Last Friday’s Drop Says About Its Q4 Prospects An AI Play Hiding in Plain Sight: A Look at Johnson Controls Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability AppLovin Drops 14%: Should Investors Worry About SEC Probe? Advanced Micro Devices Eyes $300 as AI Demand Surges From Bulldozers to Big Data: Caterpillar’s Bull Case Gets a Lift Why Analysts Are Upgrading Ratings After Klarna's IPO 3 Healthcare Companies Insiders Are Buying Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
